Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000730179 | SCV000857896 | uncertain significance | not provided | 2017-11-13 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001849086 | SCV002104566 | uncertain significance | Hereditary spastic paraplegia | 2021-10-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002535144 | SCV003718623 | uncertain significance | Inborn genetic diseases | 2022-06-24 | criteria provided, single submitter | clinical testing | The c.953T>G (p.V318G) alteration is located in exon 4 (coding exon 4) of the CYP7B1 gene. This alteration results from a T to G substitution at nucleotide position 953, causing the valine (V) at amino acid position 318 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |